Syntis Bio
Developing the next generation of drug delivery systems to enable safe and efficient delivery of therapeutics through the gastrointestinal tract as well as developing novel ingestible electronic devices for sensing a broad array of physiologic and pathophysiologic parameters.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | $33.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Syntis Bio is a cutting-edge biotech startup that operates in the healthcare sector, focusing on the development of innovative drug delivery systems and ingestible electronic devices. The company's primary aim is to revolutionize the way therapeutics are delivered through the gastrointestinal tract, making it safer and more efficient. Additionally, they are working on creating devices that can sense a wide range of physiological and pathological parameters, potentially transforming diagnostics and treatment monitoring.
The company is led by a team of highly accomplished professionals, including CEO Giovanni Traverso, a gastroenterologist and biomedical engineer with a research focus on drug delivery systems, and Robert Langer, a co-founder and chair of the Scientific Advisory Board, who is recognized as one of the most influential engineers in history.
Syntis Bio's business model revolves around the research, development, and commercialization of their innovative healthcare solutions. They generate revenue through the licensing and sublicensing of their patented technologies to other companies in the healthcare sector. Additionally, they may also earn income through the sale of their products once they have been approved for use in the market.
Their target clients include healthcare providers, hospitals, and other medical institutions that are looking for more efficient and effective ways to deliver therapeutics and monitor patient health. Given the universal need for improved healthcare solutions, Syntis Bio operates in a vast and ever-growing market.
Keywords: Biotech, Healthcare, Drug Delivery Systems, Ingestible Electronic Devices, Therapeutics, Gastrointestinal Tract, Licensing, Patented Technologies, Healthcare Providers, Medical Institutions.